Literature DB >> 25469252

Effect of rosuvastatin on atrial structural remodeling in rabbits with myocardial infarction.

Weijie Wang1, Yujiao Zhang2, Mei Gao3, Jiangrong Wang3, Yinglong Hou3.   

Abstract

The present study aimed to investigate the effect of rosuvastatin on atrial structural remodeling in rabbits with myocardial infarction (MI). The rabbits were randomly divided into 4 groups: The sham operation group (S; n=8), the MI group (MI; n=7), the group with low-dose rosuvastatin [Rs; 2.5 mg/(kg/d), n=7] and the group with high-dose rosuvastatin [Rl, 5 mg/(kg/d), n=8]. A rabbit MI model was established via ligation of the anterior descending coronary artery. After 8 weeks of intervention, the left atrial diameter (LAD), atrial collagen content, expression level of type I collagen and left ventricular ejection fraction (LVEF) were measured. LAD in the MI group was significantly larger than the S, Rs and Rl groups after 8 weeks. The left atrial collagen content of the MI group was also significantly greater than those observed in the other 3 groups. The expression of type I collagen in the MI group was significantly increased compared to the other 3 groups. However, LVEF of the MI group was lower compared to the other 3 groups. There were no significant differences between the Rs and Rl groups in the above indexes. In conclusion, rosuvastatin can improve post-MI atrial structural remodeling.

Entities:  

Keywords:  atrial structural remodeling; myocardial infarction; rabbit; rosuvastatin

Year:  2014        PMID: 25469252      PMCID: PMC4251138          DOI: 10.3892/br.2014.366

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  17 in total

1.  Effect of simvastatin on collagen I deposition in non-infarcted myocardium: role of NF-κB and osteopontin.

Authors:  Jianhua Zhang; Yan Xu; Lingxin Pan; Ting Chen; Zhiwu Chen; Ren Zhao
Journal:  Can J Physiol Pharmacol       Date:  2010-11       Impact factor: 2.273

2.  Restrictive left ventricular filling pattern and risk of new-onset atrial fibrillation after acute myocardial infarction.

Authors:  Doron Aronson; Diab Mutlak; Fadel Bahouth; Rema Bishara; Haim Hammerman; Jonathan Lessick; Shemy Carasso; Saleem Dabbah; Shimon Reisner; Yoram Agmon
Journal:  Am J Cardiol       Date:  2011-04-15       Impact factor: 2.778

Review 3.  Practical prevention of cardiac remodeling and atrial fibrillation with full-spectrum antioxidant therapy and ancillary strategies.

Authors:  Mark F McCarty
Journal:  Med Hypotheses       Date:  2010-01-18       Impact factor: 1.538

4.  Gadolinium decreases stretch-induced vulnerability to atrial fibrillation.

Authors:  F Bode; A Katchman; R L Woosley; M R Franz
Journal:  Circulation       Date:  2000-05-09       Impact factor: 29.690

5.  Simvastatin inhibited cardiac hypertrophy and fibrosis in apolipoprotein E-deficient mice fed a "Western-style diet" by increasing PPAR α and γ expression and reducing TC, MMP-9, and Cat S levels.

Authors:  Yan-wen Qin; Ping Ye; Ji-qiang He; Li Sheng; Lu-ya Wang; Jie Du
Journal:  Acta Pharmacol Sin       Date:  2010-09-13       Impact factor: 6.150

6.  Mechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor-beta1 in cultured cardiac fibroblasts.

Authors:  Kou-Gi Shyu; Bao-Wei Wang; Wei-Jan Chen; Peiliang Kuan; Chi-Ren Hung
Journal:  Eur J Heart Fail       Date:  2010-03       Impact factor: 15.534

7.  Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.

Authors:  Ana M Briones; Natalia Rodríguez-Criado; Raquel Hernanz; Ana B García-Redondo; Raul R Rodrigues-Díez; María J Alonso; Jesús Egido; Marta Ruiz-Ortega; Mercedes Salaices
Journal:  Hypertension       Date:  2009-05-18       Impact factor: 10.190

8.  Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling.

Authors:  Chia-Ti Tsai; Ling-Ping Lai; Kuan-Ting Kuo; Juey-Jen Hwang; Chia-Shan Hsieh; Kuan-Lih Hsu; Chuen-Den Tseng; Yung-Zu Tseng; Fu-Tien Chiang; Jiunn-Lee Lin
Journal:  Circulation       Date:  2008-01-02       Impact factor: 29.690

Review 9.  Statins as anti-arrhythmics: a systematic review part II: effects on risk of ventricular arrhythmias.

Authors:  Hussam Abuissa; James H O'Keefe; Kevin A Bybee
Journal:  Clin Cardiol       Date:  2009-10       Impact factor: 2.882

10.  The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model.

Authors:  Koichiro Kumagai; Hideko Nakashima; Keijiro Saku
Journal:  Cardiovasc Res       Date:  2004-04-01       Impact factor: 10.787

View more
  2 in total

1.  Rho kinase inhibitor fasudil mitigates high-cholesterol diet-induced hypercholesterolemia and vascular damage.

Authors:  Nibrass Taher Abdali; Awny H Yaseen; Eman Said; Tarek M Ibrahim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-18       Impact factor: 3.000

2.  Effects of rosuvastatin on atrial nerve sprouting and electrical remodeling in rabbits with myocardial infarction.

Authors:  Xujuan Hou; Yujiao Zhang; Ximin Wang; Shaohua Zheng; Yinglong Hou; Mei Gao
Journal:  Int J Clin Exp Med       Date:  2015-05-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.